Cornerstone Therapeutics, Inc. (CRTX) Misses Q3 EPS by 1c, Sales Fall Below Expectations
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street rallies after Democrats win Congress; data center stocks slide
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts CRTX Hot Sheet
Price: $1.95 --0%
Financial Fact:
Weighted-average common shares, basic: 26.52M
Today's EPS Names:
ATS, SICP, FTCO, More
Financial Fact:
Weighted-average common shares, basic: 26.52M
Today's EPS Names:
ATS, SICP, FTCO, More
Join SI Premium – FREE
Cornerstone Therapeutics, Inc. (NASDAQ: CRTX) reported Q3 non-GAAP EPS of $0.13, $0.01 worse than the analyst estimate of $0.14. Revenue for the quarter came in at $25.18 million versus the consensus estimate of $28.39 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Southwest Gas (SWX) Tops Q3 EPS by 2c; Offers Guidance
- SmartRent (SMRT) Reports In-Line Q3 EPS
- CPS Technologies (CPSH) Reports In-Line Q3 EPS
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
